ICM
BIOX icon

Invenomic Capital Management’s Bioceres Crop Solutions BIOX Stock Holding History

Invenomic Capital Management’s Portfolio BIOX Stock Details BIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,121
Closed -$195K – 126
2021
Q1 		$195K Buy
+19,121
New +$160K 0.04% 113

Other funds holding BIOX

Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PSCM
Prince Street Capital Management New York $40.3M AUM 0.66% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ADMI
Albert D. Mason Inc Boston, Massachusetts $176M AUM 40.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Invenomic Capital Management's BIOX Position: Q2 2021 in Review

Invenomic Capital Management sold out of Bioceres Crop Solutions (BIOX) in Q2 2021, closing a stake of 19,121 shares — an estimated $195K sold.

Invenomic Capital Management first reported a position in BIOX in Q1 2021 and held it in 1 quarter. The position peaked at $195K in Q1 2021. 19 funds tracked by Wall St. Rank hold BIOX as of Q2 2021.

  • Invenomic Capital Management reported no remaining Bioceres Crop Solutions position as of Q2 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 19,121 Bioceres Crop Solutions shares in Q2 2021, an estimated $195K.
  • Invenomic Capital Management first reported a position in Bioceres Crop Solutions in Q1 2021 and held it in 1 quarter.
  • Invenomic Capital Management's Bioceres Crop Solutions position peaked at $195K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q2 2021.

Based on Invenomic Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.